Key Highlights of the Report: The PARP inhibitor market has experienced significant growth in recent years, driven by increasing cancer incidence and advancements in targeted cancer therapies. The market is projected to expand at a robust CAGR over the forecast period, reflecting rising adoption and awareness of PARP inhibitors in oncology. PARP inhibitors are primarily used in the treatment of...